Yanjie Lin

729 total citations
24 papers, 373 citations indexed

About

Yanjie Lin is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yanjie Lin has authored 24 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Hepatology and 4 papers in Molecular Biology. Recurrent topics in Yanjie Lin's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (10 papers). Yanjie Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (10 papers). Yanjie Lin collaborates with scholars based in China, United States and Singapore. Yanjie Lin's co-authors include Xiaoyue Bi, Minghui Li, Yao Xie, Wei Yi, Mengjiao Xu, Yuanjiao Gao, Zhan Zeng, Hongxiao Hao, Praveen Linga and Hari Prakash Veluswamy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Yanjie Lin

24 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanjie Lin China 9 114 109 75 40 37 24 373
Caixia Gao China 13 194 1.7× 182 1.7× 25 0.3× 29 0.7× 38 1.0× 42 594
Xingxing Gao China 13 176 1.5× 95 0.9× 40 0.5× 24 0.6× 12 0.3× 28 556
Chunlei Chen China 13 161 1.4× 94 0.9× 51 0.7× 25 0.6× 11 0.3× 26 548
Zhu China 10 127 1.1× 31 0.3× 27 0.4× 9 0.2× 11 0.3× 92 447
Felipe Rodríguez Chile 16 159 1.4× 33 0.3× 14 0.2× 13 0.3× 17 0.5× 33 596
Linshuang Zhang China 12 151 1.3× 43 0.4× 13 0.2× 31 0.8× 41 1.1× 20 393
Ding‐Ding Guo China 10 141 1.2× 26 0.2× 9 0.1× 38 0.9× 6 0.2× 19 400
Ke Zhao China 12 170 1.5× 59 0.5× 16 0.2× 54 1.4× 6 0.2× 46 577
Ke Zhao China 10 88 0.8× 53 0.5× 19 0.3× 7 0.2× 20 0.5× 24 369
Lukáš Pfeifer Germany 12 69 0.6× 104 1.0× 33 0.4× 15 0.4× 3 0.1× 33 435

Countries citing papers authored by Yanjie Lin

Since Specialization
Citations

This map shows the geographic impact of Yanjie Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjie Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjie Lin more than expected).

Fields of papers citing papers by Yanjie Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjie Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjie Lin. The network helps show where Yanjie Lin may publish in the future.

Co-authorship network of co-authors of Yanjie Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjie Lin. A scholar is included among the top collaborators of Yanjie Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjie Lin. Yanjie Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xinxin, Weihua Cao, Ziyu Zhang, et al.. (2024). Nanoparticles and their application in the diagnosis of hepatocellular carcinoma. Nanotechnology Reviews. 13(1). 1 indexed citations
2.
Zhang, Ziyu, Weihua Cao, Xinxin Li, et al.. (2024). Nanoparticles and the treatment of hepatocellular carcinoma. Nanotechnology Reviews. 13(1). 1 indexed citations
3.
Wu, Shuling, Yang Liu, Xiaoyue Bi, et al.. (2023). Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus. SHILAP Revista de lepidopterología. 1(1). 5–10. 2 indexed citations
4.
Li, Minghui, Fangfang Sun, Xiaoyue Bi, et al.. (2022). Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection. Hepatology International. 17(1). 42–51. 5 indexed citations
5.
Chen, Xiaoxue, Wei Yi, Yang Liu, et al.. (2022). Pathway of Cell Death and Its Role in Virus Infection. Viral Immunology. 35(7). 444–456. 8 indexed citations
6.
Wu, Shuling, et al.. (2022). Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report. Infectious Agents and Cancer. 17(1). 30–30. 4 indexed citations
7.
Xu, Mengjiao, Yang Liu, Yanjie Lin, et al.. (2022). Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma. Journal of Nanobiotechnology. 20(1). 427–427. 36 indexed citations
8.
Cao, Weihua, Lu Zhang, Xiaoyue Bi, et al.. (2022). Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment. Frontiers in Immunology. 13. 891424–891424. 5 indexed citations
9.
Hao, Hongxiao, Tingting Jiang, Wen Deng, et al.. (2022). Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection. Frontiers in Immunology. 13. 893628–893628. 4 indexed citations
10.
Zeng, Zhan, Wei Yi, Qiqi Chen, et al.. (2022). Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury. Frontiers in Pharmacology. 13. 962480–962480. 2 indexed citations
11.
Li, Minghui, Xiaoyue Bi, Fangfang Sun, et al.. (2022). An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients. Frontiers in Microbiology. 13. 960589–960589. 3 indexed citations
12.
Li, Minghui, Yuanjiao Gao, Yang Liu, et al.. (2022). Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Frontiers in Immunology. 13. 1024333–1024333. 4 indexed citations
13.
Li, Minghui, Fangfang Sun, Xiaoyue Bi, et al.. (2022). Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients. Virologica Sinica. 37(3). 390–397. 18 indexed citations
14.
Wu, Shuling, Wei Yi, Yuanjiao Gao, et al.. (2022). Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection. Frontiers in Immunology. 13. 893512–893512. 12 indexed citations
15.
16.
Zhang, Lu, Fengxin Chen, Zhan Zeng, et al.. (2021). Advances in Metagenomics and Its Application in Environmental Microorganisms. Frontiers in Microbiology. 12. 766364–766364. 148 indexed citations
17.
Liu, Shiying, Yuxiu Liu, Bo Wan, et al.. (2019). Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study. Journal of Nutritional Science and Vitaminology. 65(4). 303–308. 33 indexed citations
18.
Fan, Yanping, et al.. (2018). Effect and safety evaluation of Qiming Granule on the treatment of nonproliferative diabetic retinopathy. SHILAP Revista de lepidopterología. 5 indexed citations
19.
Lin, Yanjie, Hari Prakash Veluswamy, & Praveen Linga. (2018). Effect of Eco-Friendly Cyclodextrin on the Kinetics of Mixed Methane–Tetrahydrofuran Hydrate Formation. Industrial & Engineering Chemistry Research. 57(17). 5944–5950. 35 indexed citations
20.
Chen, Chin-Chang, Tzung-Yan Lee, Ching‐Fai Kwok, et al.. (2015). Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model. Biochemical and Biophysical Research Communications. 460(4). 1063–1068. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caixia Gao Breakdown of academic impact, for papers by Xingxing Gao Breakdown of academic impact, for papers by Chunlei Chen Breakdown of academic impact, for papers by Zhu Breakdown of academic impact, for papers by Felipe Rodríguez Breakdown of academic impact, for papers by Linshuang Zhang Breakdown of academic impact, for papers by Ding‐Ding Guo Breakdown of academic impact, for papers by Ke Zhao Breakdown of academic impact, for papers by Ke Zhao Breakdown of academic impact, for papers by Lukáš Pfeifer
Rankless by CCL
2026